DMD and Duchenne muscular dystrophy: To overcome this limit, mini- or microdystrophins were developed on the basis of observations in BMD patients who express partially functional dystrophin protein variants, which contain deletions of the central rod domain, yet are mildly affected relative to DMD patients [228,229].